Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01874197 · ClinicalTrials.gov registry record · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
A NA study of Thoracoabdominal Aortic Aneurysm, Without Rupture, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 290
- Enrollment target
- 1
- Study location
NCT01874197: Recruiting NA study of Thoracoabdominal Aortic Aneurysm, Without Rupture, sponsored by University of Washington.
NCT01874197 is a NA study of Thoracoabdominal Aortic Aneurysm, Without Rupture that is actively recruiting participants, run by University of Washington. The registered enrollment target is 290 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01874197, a NA study of Thoracoabdominal Aortic Aneurysm, Without Rupture, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
- 1
- Study location
Study Summary
An investigator-initiated, prospective, consecutively enrolling, non-randomized single institution clinical evaluation of the safety and effectiveness of branched and fenestrated-branched endovascular stent grafts to preserve branch vessels when used in the treatment of patients with thoraco-abdominal aortic aneurysms. The study evaluates non-FDA-approved off the shelf and custom made branched and fenestrated-branched stent grafts manufactured by Cook Medical. The primary objectives of this study are to determine whether fenestrated-branched and branched endovascular grafts are a safe and effective method of treating patients with thoraco-abdominal aortic aneurysms.
Conditions Studied
Interventions
- DEVICE B-TEVAR device
Study Locations (1)
Washington
- University of Washington/Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2012-08 |
| Est. Completion | 2028-08 |
| Phase | NA |
What NCT01874197 shows while recruiting
NCT01874197 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Thoracoabdominal Aortic Aneurysm, Without Rupture appearing as the primary indexed condition, and to 1 intervention - of which B-TEVAR device is the first listed.
NCT01874197 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01874197 about?
NCT01874197 is a clinical study titled "Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic". An investigator-initiated, prospective, consecutively enrolling, non-randomized single institution clinical evaluation of the safety and effectiveness of branched and fenestrated-branched endovascular stent grafts to preserve branch vessels when used in the treatment of patients with thoraco-abdomin...
What is the current status of trial NCT01874197?
This trial is currently recruiting. It is a NA study. The enrollment target is 290 participants. The study started on 2012-08. Estimated completion is 2028-08.
What conditions does trial NCT01874197 study?
This clinical trial studies the following conditions: Thoracoabdominal Aortic Aneurysm, Without Rupture.
What interventions are being tested in trial NCT01874197?
The interventions under investigation include: B-TEVAR device (DEVICE).
Who is sponsoring clinical trial NCT01874197?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01874197 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01874197's enrollment target sits among peer trials
290 375th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
- NCT05056857 · 290 participants
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia